Professional Traders

[PoemStone]

SHP. ShangPharma Announces Second Quarter 2012 Results
http://finance.yahoo.com/news/shangpharma-announces-second-quarter-2012-100000979.html


SHANGHAI, Aug. 20, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its unaudited financial results for the second quarter ended June 30, 2012.

Second Quarter 2012 Highlights

Net revenues increased by 15.7% year-over-year to $31.8 million.
Net revenues from the Company's top-10 customers increased by 21.3% year-over-year to $20.6 million, representing approximately 64.8% of total net revenues.
Net revenues from full-time-equivalent ("FTE")-based services increased by 21.0% year-over-year to $23.9 million.
GAAP gross margin was 27.8%, compared with 33.3% in the second quarter of 2011. Non-GAAP gross margin was 29.0%, compared with 34.7% in the second quarter of 2011.
GAAP operating margin was 2.4%, compared with 10.3% in the second quarter of 2011. Non-GAAP operating margin was 7.6% compared with 15.2% in the second quarter of 2011.